Loading clinical trials...
Loading clinical trials...
To determine if treatment with BG00012 can decrease the number of MS relapses during a certain time period. To determine if, over time, BG00012 treatment can decrease the number of certain types of br...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Biogen
NCT05758831 · Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis
NCT06586177 · Relapsing-remitting Multiple Sclerosis
NCT05906992 · Relapsing-remitting Multiple Sclerosis
NCT05755061 · Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis
NCT07517185 · Relapsing-remitting Multiple Sclerosis
Research Site
Gilbert, Arizona
Research Site
Phoenix, Arizona
Research Site
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions